Liver bridging techniques in the treatment of acute liver failure

Journal of Investigative Surgery

Volumn 13, Issue 6, 2000, Pages 299-311

  Palmes, D ^a   Qayumi, K A ^b   Spiegel, H U ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Acute liver failure; Artificial liver support; Auxiliary liver transplantation; Hepatocyte transplantation; Liver bridging

Indexed keywords

CYCLOSPORIN; CYCLOSPORIN A; METHYLPREDNISOLONE;

ARTICLE; ARTIFICIAL LIVER; CELL TRANSPLANTATION; CONTROLLED STUDY; DEATH; DEVICE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; INTRACRANIAL HYPERTENSION; LIVER CELL; LIVER FAILURE; LIVER FUNCTION; LIVER ISCHEMIA; LIVER TRANSPLANTATION; PORTAL HYPERTENSION; PRIORITY JOURNAL; RISK FACTOR; SURVIVAL RATE;

HEPATOCYTES; HUMANS; LIVER FAILURE, ACUTE; LIVER REGENERATION; LIVER, ARTIFICIAL; RECOVERY OF FUNCTION;

EID: 0034521298     PISSN: 08941939     EISSN: None     Source Type: Journal    
DOI: 10.1080/089419300750059343     Document Type: Article

References (66)

1. Transplantation of small donor livers in adult recipients
2. Intrasplenic transplantation of allogeneic hepatocytes prolongs survival in anhepatic rats
3. Development of bioartificial liver: Bilirubin conjugation in Gunn rats
4. Liver transplantation for fulminant hepatic failure
5. Hepatocyte transplantation
6. Development of a small-scale bioreactor for drug metabolism studies maintaining hepatospecific functions
7. Reconstruction of liver tissue in vitro: Geometry of characteristic flat bed, hollow fiber, and spouted bed bioreactors with reference to the in vivo liver
8. Percutaneous hepatocyte transplantation (PHT) in liver failure
9. Auxiliary partial orthotopic liver transplantation for fulminant hepatic failure. The Paul Brousse experience
10. Liver transplantation in Europe for patients with acute liver failure
11. Acute hepatic failure treated by cross circulation
12. Clinical experience with a porcine hepatocyte-based liver support system
13. Auxiliary liver transplantation: Regeneration of the native liver and outcome in 30 patients with fulminant hepatic failure - A multicenter European study
14. Observations on rat spleen reticulum during the development of syngeneic hepatocellular implants
15. Artificial liver support in acute liver failure
16. Rejection of allogeneic hepatocytes and fetal hepatic tissue transplanted into the rat spleen
17. Heterologous liver perfusion in treatment of hepatic failure
18. Pilot-controlled trial of the extracorporeal liver assist device in acute liver failure
19. Functional analysis of grafts from living donors. Implications for the treatment of older recipients
20. The use of ABO-incompatible grafts in liver transplantation: A life-saving procedure in highly selected patients
21. Liver transplantation for acute liver failure
22. Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation
23. Charcoal haemoperfusion in the treatment of fulminant hepatic failure
24. Use of hepatocytes in adhesion and suspension cultures for liver support bioreactors
25. Improved hepatocyte in vitro maintenance in a culture model with woven multicompartment capillary systems: Electron microscopy studies
26. Development of a hybrid liver support system: A review
27. Principles of therapeutic liver repopulation
28. Transplantation of genetically modified autologous hepatocytes into non-human primates: Feasibility and short-term toxicity
29. Is "terminal" Liver damage reversible? Value, practicality and future of bridging techniques for the liver
30. Auxiliary partial orthotopic liver transplantation (APOLT) for fulminant hepatic failure: First successful case report
31. Liver transplantation across ABO blood group barriers
32. Reduction of serum cholesterol in Watanabe rabbits by xenogeneic hepatocellular transplantation
33. Mechanisms of cell engraftment during liver repopulation with hepatocyte transplantation
34. Hepatocytes exhibit superior transgene expression after transplantation into liver and spleen compared with peritoneal cavity or dorsal fat pad: Implications for hepatic gene therapy
35. Human fetal hepatocyte transplantation in patients with fulminant hepatic failure
36. Hepatic biliary transport after hepatocyte transplantation in Eizai hyperbilirubinemic rats
37. Histopathological heterogeneity in fulminant hepatic failure
38. Auxiliary liver transplantation in the rat, influence of the condition of the recipient's liver on the fate of the graft
39. Adenovirus-mediated gene therapy of liver diseases
40. The artificial liver - An interim report
41. Long-term, near-total liver replacement by transplantation of isolated hepatocytes in rats treated with retrorsine
42. New therapeutic aspects in fulminant hepatic failure
43. Hepatocellular transplantation - From the beginning to clinical application
44. Hepatocellular transplantation for metabolic deficiencies: Decrease of plasms bilirubin in Gunn rats
45. Hepatocyte transplantation: Past, present and future
46. Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure
47. Auxiliary partial orthotopic liver transplantation for acute liver failure: The Hannover experience
48. Role of thyroid hormone in stimulating liver repopulation in the rat by transplanted hepatocytes
49. Zoonosis in xenotransplantation
50. Rapid clearance of transplanted hepatocytes from pulmonary capillaries in rats indicates a wide safety margin of liver repopulation and the potential of using surrogate albumin particles for safety analysis
51. Studies of liver repopulation using the dipeptidyl peptidase IV-deficient rat and other rodent recipients: Cell size and structure relationships regulate capacity for increased transplanted hepatocyte mass in the liver lobule
52. Controlled trial of exchange-transfusion therapy in fulminant hepatitis
53. Extracorporeal support and hepatocyte transplantation in acute liver failure and cirrhosis
54. Development of a hybrid bioartificial liver
55. Hepatocellular transplantation into the lung for temporary support of acute liver failure in the rat
56. Auxiliary liver transplantation for acute liver failure
57. Treatment of fulminant hepatic failure by polyacrylonitrile-membrane haemodialysis
58. Hepatocellular transplantation for treatment of D-galactosamine-induced acute liver failure in rats
59. Extracorporeal assist of anhepatic animals with liver slice perfusion
60. Hepatocyte transplantation for the treatment of human disease
61. Hepatocyte transplantation as a bridge to orthotopic liver transplantation in terminal liver failure
62. Reversal of fulminant hepatic failure using an extracorporeal liver assist device
63. Auxiliary heterotopic liver transplantation
64. Auxiliary partial liver transplantation for end-stage chronic liver disease
65. Auxiliary versus orthotopic liver transplantation for acute liver failure. EURALT study group. European auxiliary liver transplant registry
66. Hepatic regeneration. Effects of age, sex hormone status, prolactin, and cyclosporine